---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-189064"
form_type: "8-K"
ticker: "GH"
cik: "0001576280"
company_name: "Guardant Health, Inc."
filed_at: "2022-07-07T23:59:59+00:00"
generated_at: "2026-06-24T19:37:48.479071+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Guardant Health appoints Steve E. Krognes to board of directors

## Summary
- Appointed as Class III director effective June 30, 2022, term expiring at 2024 annual meeting.
- Will serve as audit committee chair and on the nominating and corporate governance committee.
- Krognes previously CFO of Denali Therapeutics and Genentech; over 20 years biotech/life sciences.
- Will receive standard non-employee director compensation: stock option and RSU each valued at $362,500.
- Also enters into standard indemnification agreement with the Company.

## SEC filing metadata
- accession: 0001193125-22-189064
- form_type: 8-K
- ticker: GH
- cik: 0001576280
- company_name: Guardant Health, Inc.
- filed_at: 2022-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/0001193125-22-189064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/d288735d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-189064
- JSON: https://secwatch.observer/filing/0001193125-22-189064.json
- Plain text: https://secwatch.observer/filing/0001193125-22-189064.txt

## Key facts
- Executive change
  Steve E. Krognes was appointed as Class III director at Guardant Health, Inc..
  - Action: appointed
  - Role: Class III director
  source text: Effective June 30, 2022, the Board of Directors (the “ Board ”) of Guardant Health, Inc. (the “ Company ”) increased the number of directors on the Board to eight and appointed Steve E. Krognes as a Class III director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1576280/000119312522189064/0001193125-22-189064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.